$800,000 Million Fine for Morgan Stanley
Not good news for Morgan Stanley. The Financial Industry Regulatory Authority (FINRA) has recently censured and fined the firm $800,000 for several public disclosure failures. These findings, which the firm neither admits nor denies, center on alleged violations of FINRA's rules that require conflict disclosures for research analysts.
FINRA's action is the result of its findings that the firm did not disclose to customers the availability of independent research, which is required under the 2003 Research Analyst Settlement. The fine and censure were also said by FINRA to have been determined with consideration of Morgan Stanley's self-review and self-reporting, remedial actions and a prior 2005 settlement on research disclosure rules.
What went wrong for Morgan Stanley? According to FINRA, for a period of over four years between 2006 and 2010, the firm did not include conflicts that existed between Morgan Stanley itself, or its analysts and the companies reported on in their research. FINRA also found that the firm failed, over a period between 2007 and 2008, to disclose in nearly 130,000 account statements that independent, third-party research was available to customers. This was part of the 2003 Research Analyst Settlement that the SEC entered into with top securities firms, that was also included in a separate agreement with FINRA.
In the recent action by FINRA, it found the firm's research reports were not accurate. In fact, FINRA quantified the deficiencies, saying the reports included over 6,000 deficient disclosures in a like number of equity research reports. Another area of disclosure failure was in the public appearance of research analysts.
Some of the disclosure failures included, among others, such conflicts as an analyst's or household's holdings in a reviewed company, Morgan Stanley's revenues from subject companies, the firm's role as manager or co-manager of public offerings of subject companies and the firm's role as a market maker for certain subject companies' securities.
The firm will remain under the disclosure microscope for the next two years. Every six months, they will be required to certify to FINRA their compliance with the research analyst conflict of interest rules after reviewing a sampling of their research reports.
In a harshly worded statement, FINRA's Executive Vice President and Acting Chief of Enforcement James S. Shorris said that the "case strikes at the heart of FINRA's research disclosure requirements, which were written in response to scandals involving research analyst conflicts of interest." He went on to say that these failures deprived the public of important information.
For more information on the disclosure requirement for research analysts and reports, please contact Wall Street's Gusrae Kaplan Nusbaum PLLC. The firm represents broker and dealers in all aspects of regulatory compliance as well as securities and commodities litigation. Please visit our website for more information on our practice and our lawyers.



